Clovis Oncology (CLVS) Upgraded at Royal Bank of Canada

James Marshall
March 19, 2018

Hanseatic Management Services Inc sold 10,800 shares as the company's stock declined 20.61% while stock markets rallied. The hedge fund run by Remy Trafelet held 697,556 shares of the marine transportation company at the end of 2017Q3, valued at $15.77 million, down from 837,584 at the end of the previous reported quarter. Hanseatic Management Services Inc who had been investing in Clovis Oncology Inc for a number of months, seems to be less bullish one the $2.97B market cap company.

Clovis Oncology (CLVS) traded down $0.31 on Tuesday, reaching $58.72. About 115,966 shares traded.

Clovis Oncology (NASDAQ:CLVS) was upgraded by Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a research note issued on Thursday, February 22nd, Marketbeat reports. It has outperformed by 266.01% the S&P500.

Iberiabank Corp decreased its stake in Vf Corp (VFC) by 8.87% based on its latest 2017Q3 regulatory filing with the SEC. The institutional investor held 2,893 shares of the health care company at the end of 2017Q3, valued at $238,000, down from 13,693 at the end of the previous reported quarter. Insiders have sold 19,500 shares of company stock worth $1,178,730 over the last ninety days. Loss per share was $1.04 compared to our estimated loss per share of $1.23, as a result of a one-time $11.5 million benefit from a legal settlement. K12 Inc. (NYSE:LRN) has risen 71.24% since March 16, 2017 and is uptrending. It has outperformed by 29.75% the S&P500.

Among 24 analysts covering Xilinx Inc.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 52% are positive.

Analysts await Electronic Arts Inc. Victory Cap Mngmt invested in 76,768 shares. (NYSE:NOW) earned "Buy" rating by Mizuho on Friday, January 22. The firm has "Buy" rating by Stifel Nicolaus given on Monday, January 23. Benchmark maintained Electronic Arts Inc. The company was maintained on Wednesday, August 24 by SunTrust. The stock of Delphi Technologies PLC (NYSE:DLPH) earned "Buy" rating by UBS on Thursday, September 28. The rating was maintained by WallachBeth Capital with "Hold" on Wednesday, December 21. The firm has "Buy" rating by Argus Research given on Thursday, October 15. The stock of ServiceNow, Inc. The rating was maintained by Barclays Capital with "Overweight" on Tuesday, February 27.

Since September 27, 2017, it had 0 insider purchases, and 5 insider sales for $1.01 million activity. Bancorpsouth Inc now has $3.04 billion valuation. (NASDAQ:XLNX) on Thursday, February 1. The insider Schatz Jacob J. sold $125,370.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.39, from 1.44 in 2017Q2. 31 funds opened positions while 37 raised stakes. (NASDAQ:CLVS) for 4,053 shares. The Missouri-based Atwood And Palmer has invested 0% in Clovis Oncology, Inc. California Public Employees Retirement System now owns 29,900 shares of the biopharmaceutical company's stock worth $2,800,000 after purchasing an additional 2,300 shares during the period. Moreover, Marshall Wace Limited Liability Partnership has 0.07% invested in Clovis Oncology, Inc. (NASDAQ:XLNX) for 6,030 shares. Voya Investment Mgmt Ltd holds 0% of its portfolio in K12 Inc. American Century owns 734,221 shares. Cliftonlarsonallen Wealth Ltd stated it has 0.09% of its portfolio in V.F. Corporation (NYSE:VFC). (NASDAQ:XLNX) for 123 shares. Blair William Com Il owns 75,660 shares for 0.04% of their portfolio. Nicholas Inv Ptnrs Lp holds 24,917 shares or 0.14% of its portfolio. (NASDAQ:XLNX) for 150 shares. Rmb Cap Mgmt Limited Liability Corp holds 0.04% or 19,140 shares in its portfolio. It also increased its holding in Vanguard Whitehall Fds Inc Emerg Mkt Bd (VWOB) by 118,175 shares in the quarter, for a total of 446,924 shares, and has risen its stake in Cabot Oil & Gas Corp (NYSE:COG).

Several brokerages recently issued reports on CLVS. They expect $0.65 earnings per share, up 18.18% or $0.10 from last year's $0.55 per share. EQR's profit will be $297.91 million for 19.30 P/E if the $0.78 EPS becomes a reality. The biopharmaceutical company reported ($1.04) EPS for the quarter, beating the Zacks' consensus estimate of ($1.29) by $0.25.

Since October 16, 2017, it had 0 buys, and 7 insider sales for $1.62 million activity. Samlyn Limited Liability Co holds 1.09% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS) rating on Tuesday, February 27.

Clovis Oncology (NASDAQ:CLVS) last posted its quarterly earnings data on Monday, February 26th. Therefore 67% are positive.

Analysts await Clovis Oncology, Inc. WallachBeth Capital maintained Clovis Oncology, Inc. Clovis Oncology presently has a consensus rating of "Buy" and an average target price of $87.84. On Monday, June 6 the stock rating was maintained by Goldman Sachs with "Buy". Deutsche Bank maintained Equity Residential (NYSE:EQR) rating on Friday, August 18. Credit Suisse maintained it with "Buy" rating and $10700 target in Tuesday, July 18 report. Peregrine Capital Management LLC now owns 143,613 shares of the biopharmaceutical company's stock worth $11,834,000 after purchasing an additional 17,443 shares during the period. Moreover, Redmile Group Llc has 4.05% invested in the company for 996,610 shares. Stifel Nicolaus maintained the shares of CLVS in report on Monday, January 23 with "Buy" rating. Morgan Stanley initiated the shares of CLVS in report on Friday, January 13 with "Overweight" rating. Raymond James downgraded the stock to "Underperform" rating in Thursday, October 6 report. (NASDAQ:CLVS) has "Overweight" rating given on Thursday, January 26 by Piper Jaffray.

Investors sentiment decreased to 1.05 in 2017 Q3. Its down 0.37, from 1.81 in 2017Q2. It dropped, as 48 investors sold CLVS shares while 49 reduced holdings. Dimensional Fund Advisors LP acquired a new stake in Clovis Oncology in the second quarter worth $2,328,000. Atwood & Palmer holds 0% or 500 shares in its portfolio. Strs Ohio holds 0% or 5,200 shares. Venbio Select Advisor Ltd Com holds 5.02% or 785,700 shares in its portfolio. Tower Research Capital Ltd (Trc) has invested 0.02% of its portfolio in Clovis Oncology, Inc.

Iguana Healthcare Management Llc decreased Lilly Eli & Co (NYSE:LLY) stake by 10,000 shares to 40,000 valued at $3.42M in 2017Q3. Gemmer Asset Management Limited Com holds 0% or 56 shares. California Pub Employees Retirement System owns 33,384 shares or 0% of their United States portfolio. Lpl Fincl Ltd holds 0% or 2,567 shares in its portfolio. Panagora Asset Mngmt, a Massachusetts-based fund reported 12,859 shares. Oppenheimer Asset invested in 0% or 14 shares.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER